News Articles for Liddy McCall

Local research institute-backed venture capital fund Health Translation Group has won the backing of global life sciences investment giant Bridgewest.

Today's board moves wrap includes Keith Rumble, Liddy McCall and Adrian Smith.

A not-for-profit investment vehicle aims to build a $100 million fund for WA investment.

Three new local funds proposing to focus on early-stage investment are raising expectations.

The commercial side of life sciences may have reached a critical mass in WA.

The recent $100 million sale of Agworld is a badge of success for WA tech but also reveals the sector's limitations.

The state government has appointed an industry reference group to develop a growth plan for WA's health and medical life sciences sector to be chaired by Peter Klinken.

SPECIAL REPORT: Tech startups in WA can raise capital if they know where to look and how to ask, a Perth seminar was told.

Melbourne-based biotech Fitgenes has brought control of its extensive health and nutrition clinics in-house.

FEATURE: Biotech and IT companies are enjoying renewed investor interest, but these innovative businesses are facing a changing capital raising market featuring less government support and, in Perth, a drastic shift in the venture capital sector.

FEATURE: The state's biotechnology sector is heating up as investors look for the next wave of investment opportunities amid waning resources investment.